Anti-tumour alkylating agents act synergistically with methylxanthines on induction of sister-chromatid exchange in human lymphocytes.
D002110:Caffeine / Q000494:pharmacology*; D002478:Cells, Cultured; D002699:Chlorambucil / Q000494:pharmacology*; D002945:Cisplatin / Q000494:pharmacology*; D003434:Crossing Over, Genetic / Q000187:drug effects*; D004357:Drug Synergism; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000502:physiology; D008558:Melphalan / Q000494:pharmacology*; D012854:Sister Chromatid Exchange / Q000187:drug effects*; D013805:Theobromine / Q000494:pharmacology
D002699:Chlorambucil; D002110:Caffeine; D013805:Theobromine; D002945:Cisplatin; D008558:Melphalan